Targeted Therapy TALK: Translating the Latest Advances into Precision Care for ALK-positive Advanced NSCLC

Deepen your understanding of ALK rearrangement biomarker testing and the latest data for managing patients with ALK-positive advanced NSCLC via expert-written ClinicalThought commentaries, downloadable slides, an on-demand webcast, and practical downloadable resources.

Share

Program Content

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.